期刊文献+

达利全治疗顽固性心力衰竭临床分析

The clinical analysis of the efficacy of the Dilatrend in refractory heart failure
暂未订购
导出
摘要 目的探讨达利全是否为顽固性心力衰竭的理想治疗药物。方法在常规治疗效果差的基础上,对顽固性心力衰竭采用达利全治疗,在用药前及用药3个月后行彩色超声心动图检查,以测定心脏泵功能及左室收缩和舒张功能变化,观察用药前后心功能变化。结果显效率为28%,总有效率80%;CO,CI和EF均有明显改善,但LVEDD未见明显缩小。结论达利全可以明显改善顽固性心力衰竭的心功能。 Objective To explore whether Dilatrend was a ideal treatment drug for refractory heart failure. Methods To those patients with refractory heart failure whose normal treatment had little effect on, Dilatrend was added, the colorful eehoeardiography was performed, before and after three months of the treatment, to evaluate cardiac pumping function and changes of left ventrieular systolic and diastolic function, and to observe the change of cardiac function before and after the treatment. Results The present efficiency rate was 28%, and the total efficiency rate was 80%. The cardiac output (CO), the cardiac index (CI) and the left ventricular ejection fraction (LVEF) were all improved significantly, but the left ventricular end-diastolic diameter (LVEDD) was not reduced obviously. Conclusion Dilatrend may significantly improve the cardiac function of the patients with refractory heart failure.
作者 吴永华
出处 《中国现代医药杂志》 2005年第6期6-7,共2页 Modern Medicine Journal of China
关键词 达利全 心力衰竭 Dilatrend Heart failure
  • 相关文献

参考文献1

二级参考文献1

共引文献84

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部